Crescent Capital BDCNASDAQ: CCAP

Crescent Capital BDC (CCAP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

If you're considering investing in dividend stocks, you'll find that there are many reasons to do so, not least the steady passive income they deliver on top of long-term capital appreciation.

Net worth is not the only metric to measure wealth, as free cash flow generation is also important. Investing in a mix of high and mid-level dividend-paying stocks can protect net worth, while providing income. Crescent Capital and Federal Realty Trust are two picks that offer high-yield and stable growth for a well-rounded portfolio.

Does Crescent Capital BDC (CCAP) have what it takes to be a top stock pick for momentum investors? Let's find out.

CCAP could potentially see an increase in its stock price due to increasing optimism about its earnings outlook, as indicated by its upgrade to a Zacks Rank #2 (Buy).

Business Development Companies such as Crescent Capital offer the chance to earn high distributions in today's high-interest rate environment. CCAP has a varied portfolio of 186 companies in various sectors, reducing the risk of overexposure. The credit quality is strong, with only 2% of non-accruals. Net investment income has been steadily increasing in recent quarters, leading to the declaration of additional distributions.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Crescent Capital BDC (CCAP) closed at $17.50 in the latest trading session, marking a +0.81% move from the prior day.

Crescent Capital BDC (CCAP) closed at $16.99 in the latest trading session, marking a -1.51% move from the prior day.